A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. — Stella
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(110 sites) United States
Honor Health Research Institute, Scottsdale, Arizona Fullerton Neuro and Headache Ctr, Fullerton, California SC3 Research Pasadena, Pasadena, California California Pacific Medical Center, Sacramento, California Neurology Offices Of South Florida, Boca Raton, Florida Superior Associates in Research LLC, Hialeah, Florida Augusta University Georgia, Augusta, Georgia Hawaii Pacific Neuroscience LLC, Honolulu, Hawaii University of Chicago Medical Centr, Chicago, Illinois Prairie Heart Institute, Springfield, Illinois Mid Atlantic Epilepsy and Sleep Ctr, Bethesda, Maryland Duke University Medical Center, Durham, North Carolina Neuroscience Research Ctr, Canton, Ohio Ohio State University Medical Center, Columbus, Ohio Penn Presbyterian Medical Center, Philadelphia, Pennsylvania Vanderbilt University Medical CenterX, Nashville, Tennessee Nerve and Muscle Center of Texas, Houston, Texas Central TX Neuro Consultants P A, Round Rock, Texas Center for Neurological Disorders G, Greenfield, Wisconsin Argentina
Novartis Investigative Site, Buenos Aires Brazil
Novartis Investigative Site, São Paulo China
Novartis Investigative Site, Hefei, Anhui Novartis Investigative Site, Guangzhou, Guangdong Novartis Investigative Site, Shenzhen, Guangdong Novartis Investigative Site, Shijiazhuang, Hebei Novartis Investigative Site, Changsha, Hunan Novartis Investigative Site, Suzhou, Jiangsu Novartis Investigative Site, Nanchang, Jiangxi Novartis Investigative Site, Xi'an, Shaanxi Novartis Investigative Site, Xianyang, Shaanxi Novartis Investigative Site, Beijing Novartis Investigative Site, Beijing Novartis Investigative Site, Beijing Novartis Investigative Site, Fujian Denmark
Novartis Investigative Site, Copenhagen France
Novartis Investigative Site, Limoges, Haute Vienne Novartis Investigative Site, Garches Novartis Investigative Site, Nice Novartis Investigative Site, Paris Novartis Investigative Site, Paris Germany
Novartis Investigative Site, Würzburg, Bavaria Novartis Investigative Site, Frankfurt am Main, Hesse Novartis Investigative Site, Bochum Greece
Novartis Investigative Site, Athens Novartis Investigative Site, Chaïdári Novartis Investigative Site, Larissa Novartis Investigative Site, Pátrai Novartis Investigative Site, Thessaloniki Israel
Novartis Investigative Site, Haifa Novartis Investigative Site, Jerusalem Italy
Novartis Investigative Site, Bologna, BO Novartis Investigative Site, Florence, FI Novartis Investigative Site, Genova, GE Novartis Investigative Site, Milan, MI Novartis Investigative Site, Palermo, PA Novartis Investigative Site, Palermo, PA Novartis Investigative Site, Roma, RM Novartis Investigative Site, Roma, RM Novartis Investigative Site, Roma, RM Novartis Investigative Site, Orbassano, TO Novartis Investigative Site, Naples Japan
Novartis Investigative Site, Narita, Chiba Novartis Investigative Site, Sapporo, Hokkaido Novartis Investigative Site, Nishinomiya, Hyōgo Novartis Investigative Site, Hanamaki, Iwate Novartis Investigative Site, Sendai, Miyagi Novartis Investigative Site, Suita, Osaka Novartis Investigative Site, Higashi-Matsuyama, Saitama Novartis Investigative Site, Shinjuku Ku, Tokyo Novartis Investigative Site, Chiba Novartis Investigative Site, Fukuoka Novartis Investigative Site, Fukushima Novartis Investigative Site, Hiroshima Poland
Novartis Investigative Site, Lublin, Lublin Voivodeship Novartis Investigative Site, Warsaw, Masovian Voivodeship Novartis Investigative Site, Krakow, POL Novartis Investigative Site, Katowice, Silesian Voivodeship Novartis Investigative Site, Bydgoszcz Novartis Investigative Site, Katowice Novartis Investigative Site, Krakow Novartis Investigative Site, Lublin Novartis Investigative Site, Poznan Novartis Investigative Site, Rzeszów Novartis Investigative Site, Warsaw Portugal
Novartis Investigative Site, Lisbon Novartis Investigative Site, Lisbon Novartis Investigative Site, Porto Novartis Investigative Site, Vila Nova de Gaia Serbia
Novartis Investigative Site, Belgrade Novartis Investigative Site, Niš South Korea
Novartis Investigative Site, Daegu Novartis Investigative Site, Gwangju Novartis Investigative Site, Seoul Novartis Investigative Site, Seoul Spain
Novartis Investigative Site, Santiago Compostela, A Coruna Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona Novartis Investigative Site, Alicante Novartis Investigative Site, Barcelona Novartis Investigative Site, Lleida Novartis Investigative Site, Madrid Novartis Investigative Site, Málaga Novartis Investigative Site, Valencia United Kingdom
Novartis Investigative Site, Inverness, Invernesshire Novartis Investigative Site, Ilford, London Novartis Investigative Site, Swinton, Manchester Novartis Investigative Site, Birmingham, West Midlands Novartis Investigative Site, Liverpool Novartis Investigative Site, London Novartis Investigative Site, Southampton
Key details Sponsor
Novartis Pharmaceuticals
Enrollment target
~146 participants
Primary completion
April 2027
Age range
18 Years – 85 Years
Last updated March 2026
Interested in joining? Novartis Investigative Site, Jinan